BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
241 hedge funds and large institutions have $5.17B invested in bluebird bio in 2017 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 95 increasing their positions, 66 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
241
Holders Change
+31
Holders Change %
+14.76%
% of All Funds
6.02%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.1%
New
50
Increased
95
Reduced
66
Closed
19
Calls
$109M
Puts
$49M
Net Calls
+$59.7M
Net Calls Change
+$34.8M
Top Buyers
Top Sellers
1 |
![]()
Franklin Resources
San Mateo,
California
|
-$50.4M |
2 |
![]()
Alyeska Investment Group
Chicago,
Illinois
|
-$25.4M |
3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$21.1M |
4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$16.6M |
5 |
State Street
Boston,
Massachusetts
|
-$16.3M |